Osterweis Capital Management »

Biomarin Pharma Inc convertible/ shares owned by Osterweis Capital Management

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Osterweis Capital Management from 13F filings

Historical chart of Osterweis Capital Management investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Osterweis Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Osterweis Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $82M 82M 0.99

More positions owned by Osterweis Capital Management

Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Biomarin Pharmaceutical Note 0.599% 8/0 (Principal)
Jazz Investments I Note 1.500% 8/1 (Principal)
Pegasystems Note 0.750% 3/0 (Principal)
Amazon (AMZN)
Blackline Note 0.125% 8/0 (Principal)
Analog Devices (ADI)
Target Corporation (TGT)
Adobe Systems Incorporated (ADBE)
Waste Connections (WCN)
Becton, Dickinson and (BDX)
Ross Stores (ROST)
Visa Com Cl A (V)
Air Products & Chemicals (APD)

View all positions for Osterweis Capital Management

Top funds holding Biomarin Pharma Inc convertible/

Osterweis Capital Management
OZ Management
Millennium Management
Lazard Asset Management
Glazer Capital
Citigroup
Aviva
Tenor Capital Management
Piper Jaffray & Co.
Partner Fund Management
Jpmorgan Chase & Co
Thrivent Financial for Lutherans
State Street Corporation
Branch Banking & Trust Company
Kohlberg Kravis Roberts & Co

View all funds holding Biomarin Pharma Inc convertible/